ATOSSA THERAPEUTICS, INC. Deferred Tax Assets, Equity Method Investments
ATOSSA THERAPEUTICS, INC. (ATOS) had Deferred Tax Assets, Equity Method Investments of $987.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsEquityMethodInvestments · last filed 2026-03-25
- 2025-12-31: Deferred Tax Assets, Equity Method Investments $987.00K.
- 2024-12-31: Deferred Tax Assets, Equity Method Investments $987.00K.
- 2023-12-31: Deferred Tax Assets, Equity Method Investments $628.00K.
- 2022-12-31: Deferred Tax Assets, Equity Method Investments $0.00.
| Period end | Deferred Tax Assets, Equity Method Investments |
|---|---|
| 2025-12-31 | $987.00K 10-K · filed 2026-03-25 |
| 2024-12-31 | $987.00K 10-K · filed 2026-03-25 |
| 2023-12-31 | $628.00K 10-K · filed 2025-03-25 |
| 2022-12-31 | $0.00 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |